ACRV
Price
$1.35
Change
+$0.11 (+8.80%)
Updated
Jun 6, 04:08 PM (EDT)
Capitalization
39.19M
63 days until earnings call
HUMA
Price
$2.65
Change
+$0.03 (+1.15%)
Updated
Jun 6, 04:24 PM (EDT)
Capitalization
406.41M
74 days until earnings call
Interact to see
Advertisement

ACRV vs HUMA

Header iconACRV vs HUMA Comparison
Open Charts ACRV vs HUMABanner chart's image
Acrivon Therapeutics
Price$1.35
Change+$0.11 (+8.80%)
Volume$300
Capitalization39.19M
Humacyte
Price$2.65
Change+$0.03 (+1.15%)
Volume$12.09K
Capitalization406.41M
ACRV vs HUMA Comparison Chart
Loading...
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRV vs. HUMA commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a Buy and HUMA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ACRV: $1.25 vs. HUMA: $2.62)
Brand notoriety: ACRV and HUMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 58% vs. HUMA: 97%
Market capitalization -- ACRV: $39.19M vs. HUMA: $406.41M
ACRV [@Biotechnology] is valued at $39.19M. HUMA’s [@Biotechnology] market capitalization is $406.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileHUMA’s FA Score has 0 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • HUMA’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACRV and HUMA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 3 TA indicator(s) are bullish while HUMA’s TA Score has 5 bullish TA indicator(s).

  • ACRV’s TA Score: 3 bullish, 3 bearish.
  • HUMA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, HUMA is a better buy in the short-term than ACRV.

Price Growth

ACRV (@Biotechnology) experienced а +13.64% price change this week, while HUMA (@Biotechnology) price change was -5.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.61%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +3.50%.

Reported Earning Dates

ACRV is expected to report earnings on Aug 08, 2025.

HUMA is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+11.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HUMA($406M) has a higher market cap than ACRV($39.2M). HUMA YTD gains are higher at: -48.119 vs. ACRV (-79.236). ACRV has higher annual earnings (EBITDA): -84.45M vs. HUMA (-137.16M). ACRV has more cash in the bank: 187M vs. HUMA (20.6M). ACRV has less debt than HUMA: ACRV (4.01M) vs HUMA (17.3M). ACRV (0) and HUMA (0) have equivalent revenues.
ACRVHUMAACRV / HUMA
Capitalization39.2M406M10%
EBITDA-84.45M-137.16M62%
Gain YTD-79.236-48.119165%
P/E RatioN/AN/A-
Revenue00-
Total Cash187M20.6M908%
Total Debt4.01M17.3M23%
TECHNICAL ANALYSIS
Technical Analysis
ACRVHUMA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 29 days ago
88%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INVA21.150.27
+1.29%
Innoviva
SCM13.230.06
+0.46%
STELLUS CAPITAL INVESTMENT Corp
SLGN53.550.08
+0.15%
Silgan Holdings
BRLT1.41N/A
-0.35%
Brilliant Earth Group
AFL102.21-0.62
-0.60%
Aflac

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
+1.63%
ALLR - ACRV
48%
Loosely correlated
-8.10%
VERV - ACRV
40%
Loosely correlated
+8.22%
AURA - ACRV
39%
Loosely correlated
-0.57%
CCCC - ACRV
38%
Loosely correlated
-4.87%
MGNX - ACRV
37%
Loosely correlated
-3.33%
More

HUMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HUMA has been loosely correlated with RXRX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HUMA jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HUMA
1D Price
Change %
HUMA100%
-0.38%
RXRX - HUMA
37%
Loosely correlated
-7.13%
AURA - HUMA
36%
Loosely correlated
-0.57%
PRLD - HUMA
36%
Loosely correlated
-0.99%
ACRV - HUMA
34%
Loosely correlated
+1.63%
BDTX - HUMA
33%
Loosely correlated
-2.36%
More